We are live on ! Find out more
HPG

Harvest Portfolios Group Portfolio holdings

AUM $7.09B
1-Year Est. Return 20.73%
This Fund
S&P 500
This Quarter Est. Return
+17.72%
1 Year Est. Return
+20.73%
3 Year Est. Return
+67.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.09B
AUM Growth
+$1.03B
Cap. Flow
+$501M
Cap. Flow %
7.06%
Top 10 Hldgs %
34.12%
Holding
274
New
14
Increased
122
Reduced
129
Closed
7
Avg Time Held
10.2 quarters
Top 10 Avg Time Held
4 quarters
Top 20 Avg Time Held
4.9 quarters

Top Buys

Rank Stock Value
1
SPCX
SpaceX
SPCX
+$71.7M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$65.7M
3
MSTR icon
Strategy Inc
MSTR
+$64.2M
4
MSFT icon
Microsoft
MSFT
+$63.3M
5
PLTR icon
Palantir
PLTR
+$48M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$84.2M
2
ZTS icon
Zoetis
ZTS
+$64.3M
3
NFLX icon
Netflix
NFLX
+$52.7M
4
ACN icon
Accenture
ACN
+$32M
5
CRM icon
Salesforce
CRM
+$24.9M

Sector Composition

Rank Sector Weight
1 Technology 32.05%
2 Healthcare 24.11%
3 Financials 9.35%
4 Communication Services 7.87%
5 Consumer Discretionary 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
VRTX icon
26
Vertex Pharmaceuticals
VRTX
$128B
$73.6M 1.04%
+148,195
New +$65.7M
2026 Q2
0 quarters
DHR icon
27
Danaher
DHR
$150B
$72.6M 1.02%
381,326
+72,656
+24% +$13.2M
2022 Q4
14 quarters
AZN icon
28
AstraZeneca
AZN
$243B
$72.2M 1.02%
380,770
+3,150
+0.8% +$592K
2022 Q4
14 quarters
SPCX
29
SpaceX
SPCX
$2.1T
$72.1M 1.02%
+422,234
New +$71.7M
2026 Q2
0 quarters
TMO icon
30
Thermo Fisher Scientific
TMO
$242B
$71.8M 1.01%
143,288
+24,841
+21% +$11.9M
2022 Q4
14 quarters
NVS icon
31
Novartis
NVS
$268B
$71.6M 1.01%
457,045
+2,364
+0.5% +$354K
2022 Q4
14 quarters
A icon
32
Agilent Technologies
A
$47.3B
$70.7M 1%
532,149
+28,130
+6% +$3.43M
2023 Q3
11 quarters
SYK icon
33
Stryker
SYK
$106B
$69.8M 0.98%
221,792
+36,588
+20% +$11.5M
2022 Q4
14 quarters
BMY icon
34
Bristol-Myers Squibb
BMY
$125B
$69.4M 0.98%
1,203,684
+15,511
+1% +$891K
2022 Q4
14 quarters
ELV icon
35
Elevance Health
ELV
$83.8B
$68.8M 0.97%
177,890
-22,302
-11% -$8.27M
2022 Q4
14 quarters
ABT icon
36
Abbott
ABT
$169B
$68.8M 0.97%
757,820
+134,089
+21% +$12.2M
2022 Q4
14 quarters
MDT icon
37
Medtronic
MDT
$110B
$66M 0.93%
843,555
+181,291
+27% +$14.6M
2022 Q4
14 quarters
CSCO icon
38
Cisco
CSCO
$442B
$65.7M 0.93%
559,256
-98,787
-15% -$10.3M
2022 Q4
14 quarters
REGN icon
39
Regeneron Pharmaceuticals
REGN
$75.7B
$65.2M 0.92%
104,616
+32,219
+45% +$21.9M
2022 Q4
14 quarters
ISRG icon
40
Intuitive Surgical
ISRG
$138B
$58.8M 0.83%
147,970
+13,247
+10% +$5.79M
2022 Q4
14 quarters
ORCL icon
41
Oracle
ORCL
$431B
$55.6M 0.78%
379,067
+36,556
+11% +$6.63M
2022 Q4
14 quarters
BSX icon
42
Boston Scientific
BSX
$61.7B
$54M 0.76%
1,264,163
+347,182
+38% +$18.9M
2022 Q4
14 quarters
SHOP icon
43
Shopify
SHOP
$195B
$52.2M 0.74%
456,444
+193,993
+74% +$22.1M
2025 Q3
3 quarters
CCJ icon
44
Cameco
CCJ
$37.1B
$51.4M 0.72%
504,064
+173,386
+52% +$19.4M
2025 Q3
3 quarters
AMAT icon
45
Applied Materials
AMAT
$429B
$50.8M 0.72%
70,301
-6,652
-9% -$3.07M
2023 Q3
11 quarters
LRCX icon
46
Lam Research
LRCX
$435B
$49.9M 0.7%
+115,142
New +$35M
2026 Q2
0 quarters
PANW icon
47
Palo Alto Networks
PANW
$330B
$48.4M 0.68%
141,837
-24,609
-15% -$5.63M
2024 Q3
7 quarters
ENB icon
48
Enbridge
ENB
$102B
$48.3M 0.68%
891,454
+130,261
+17% +$7.14M
2023 Q1
13 quarters
RY icon
49
Royal Bank of Canada
RY
$271B
$47.1M 0.66%
227,429
+16,883
+8% +$3.13M
2023 Q1
13 quarters
AEM icon
50
Agnico Eagle Mines
AEM
$93B
$46.3M 0.65%
298,291
+110,830
+59% +$20.5M
2023 Q1
13 quarters
1
2
3 4 5

Similar funds

CGPCS
Capital Group Private Client Services Los Angeles, California $7.09B AUM 30.53% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
SAM
Scopus Asset Management New York $7.11B AUM 32.62% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
BFS
Bradley Foster & Sargent Hartford, Connecticut $7.06B AUM 27.24% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $7.06B AUM 36.47% 1-Year Est. Return
AS
Aware Super Sydney, Australia $7.06B AUM

Harvest Portfolios Group's Q2 2026 Portfolio in Review

As of Q2 2026, Harvest Portfolios Group held 274 positions worth $7.09B, up 17% from $6.06B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Harvest Portfolios Group deployed $501M of net new capital in Q2 2026, opening 14 new positions and adding to 122 existing holdings. Its largest new stake was SpaceX: 422,234 shares worth $72.1M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $84.2M trimmed.

  • Harvest Portfolios Group's largest Q2 2026 buy was SpaceX: 422,234 shares worth $72.1M.
  • Harvest Portfolios Group added most to Strategy Inc in Q2 2026, an estimated $64.2M increase.
  • Harvest Portfolios Group's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $84.2M.
  • Harvest Portfolios Group fully exited Zoetis in Q2 2026, selling an estimated $64.3M.
  • Harvest Portfolios Group's ten largest holdings make up 34% of its $7.09B portfolio in Q2 2026.
  • Harvest Portfolios Group opened 14 new positions and closed 7 in Q2 2026.
  • Harvest Portfolios Group's portfolio value rose 17% quarter-over-quarter to $7.09B.

Based on Harvest Portfolios Group's 13F filing for Q2 2026, filed 13 Aug 2026.